Updates

Big Pharma Earnings Watch: Bristol-Myers Squibb, AstraZeneca, Roche

Jul 29, 2019

Three More Drug Makers Top Earnings Expectations in Q2   Today three more Read More

CSRxP: Senate Finance Takes Positive Steps to Hold Big Pharma Accountable, Lower Drug Prices

Jul 25, 2019

Commends Bipartisan Collaboration on Several Market-Based Solutions Read More

Big Pharma Earnings Watch: GlaxoSmithKline

Jul 24, 2019

Big Pharma Giants Now Three for Three Besting Forecasts After Hiking Prices Read More

CSRxP Applauds Grassley, Wyden for Moving Ahead on Drug Pricing Package

Jul 23, 2019

Looks Forward to Working With Senate Finance Members to Hold Big Pharma Read More

Big Pharma Earnings Watch: Novartis

Jul 18, 2019

Drug Makers’ Shares Hit ‘All-Time High’ Off Of Price-Gouging American Read More

Big Pharma Earnings Watch: Johnson & Johnson

Jul 17, 2019

Drug Maker Bests Q2 Forecasts After Hiking Prices on Dozens of Drugs in 2019 Read More

CSRxP Encourages House E&C Lawmakers to Advance FAIR Drug Pricing Act

Jul 16, 2019

Greater List Price Transparency Will Help Hold Big Pharma Accountable Read More

Big Pharma Watch: Manufacturers Thumb Nose at Drug Price Crisis

Jul 12, 2019

Drug Makers Continue Price-Gouging Patients as Americans Demand Accountability Read More

Second Opinion: Correcting Big Pharma’s Claims On The Rebate Rule

Jul 12, 2019

America’s seniors and taxpayers received a huge win today when the Read More

CSRxP Applauds Administration for Withdrawal of Controversial Rebate Rule

Jul 11, 2019

Decision to Sideline Misguided Proposal a Huge Win for America’s Seniors Read More

CSRxP: STRONGER Patents Act Could Further Enable Big Pharma’s Patent Abuse

Jul 10, 2019

Proposed Bill Would Undermine Fair and Efficient Review Process Washington, Read More

In Case You Missed It: Congress must capitalize on momentum to hold Big Pharma accountable

Jul 9, 2019

Lauren Aronson The Hill July 9, 2019 The American people are demanding that Read More